These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26975597)

  • 21. Compounding bevacizumab for intravitreal injection: does USP <797> always apply?
    Shienbaum G; Flynn HW
    Retina; 2013 Oct; 33(9):1733-4. PubMed ID: 23851633
    [No Abstract]   [Full Text] [Related]  

  • 22. The United States Pharmacopeia. Its value to the professions.
    Heller WM
    JAMA; 1970 Jul; 213(4):576-9. PubMed ID: 4914287
    [No Abstract]   [Full Text] [Related]  

  • 23. [Basic tasks concerning improvement of drugs control].
    Kliuev MA
    Farmatsiia; 1967; 16(2):3-9. PubMed ID: 5611767
    [No Abstract]   [Full Text] [Related]  

  • 24. The value of USP public standards for therapeutic products.
    Bhattacharyya L; Cecil T; Dabbah R; Roll D; Schuber S; Sheinin EB; Williams RL;
    Pharm Res; 2004 Oct; 21(10):1725-31. PubMed ID: 15553215
    [No Abstract]   [Full Text] [Related]  

  • 25. Ingredients in pharmaceutical preparations: a problem not value.
    Lubner GC
    Boll Chim Farm; 2002; 141(5):332. PubMed ID: 12481372
    [No Abstract]   [Full Text] [Related]  

  • 26. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance of content requirements in pharmacopoeias].
    Hoeke M
    Pharm Weekbl; 1969 Nov; 104(45):1409-13. PubMed ID: 5355473
    [No Abstract]   [Full Text] [Related]  

  • 28. Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.
    Peters GF; McKeon MR; Weiss WT
    Am J Health Syst Pharm; 2007 Mar; 64(6):622-31. PubMed ID: 17353571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diminishing value of the Physicians' Desk Reference and drug package inserts as a medical and legal standard of medical usage of pharmaceutical drugs.
    Burkhart CG
    J Drugs Dermatol; 2005; 4(4):414-5. PubMed ID: 16004013
    [No Abstract]   [Full Text] [Related]  

  • 30. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-second report.
    World Health Organ Tech Rep Ser; 1992; 823():1-134. PubMed ID: 1462605
    [No Abstract]   [Full Text] [Related]  

  • 31. [Drug testing: progress and expectations].
    Aschenbrenner R; Lewandowski G
    Internist (Berl); 1973 Jan; 14(1):1-5. PubMed ID: 4576793
    [No Abstract]   [Full Text] [Related]  

  • 32. Compounding practices in Iran.
    Goodarzi N; Niknam S; Akbarzadeh T; Gholami K
    Int J Pharm Compd; 2014; 18(2):112-6. PubMed ID: 24881113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The essentials of United States Pharmacopeia Chapter <51> antimicrobial effectiveness testing and its application in pharmaceutical compounding.
    Vu N; Nguyen K; Kupiec TC
    Int J Pharm Compd; 2014; 18(2):123-30. PubMed ID: 24881116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacopeia and preparations for cutaneous application].
    Esnault F; Etchegaray JP; Mallard C
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S40-5. PubMed ID: 17563714
    [No Abstract]   [Full Text] [Related]  

  • 35. Compounding in Ukraine.
    Zdoryk OA; Georgiyants VA; Gryzodub OI; Schnatz R
    Int J Pharm Compd; 2013; 17(2):124-7. PubMed ID: 23696172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Information chapters in pharmacopoeias.
    Banes D
    Ann Ist Super Sanita; 1975; 11(3-4):290-5. PubMed ID: 1234730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of the Pharmacopoeia Committee of the Ministry of Public Health of the USSR in improving drug preparation quality].
    Oboĭmakova OM
    Farm Zh; 1977; 32(4):28-31. PubMed ID: 913542
    [No Abstract]   [Full Text] [Related]  

  • 38. Panel discussion: proposed changes in the USP--microbiological aspects. I. Proposed changes in the USP sterility test.
    Clapp FL
    Bull Parenter Drug Assoc; 1969; 23(6):252-4. PubMed ID: 4901566
    [No Abstract]   [Full Text] [Related]  

  • 39. WHO Expert Committee on Specifications for Pharmaceutical Preparations. 22.
    World Health Organ Tech Rep Ser; 1969; 418():1-29. PubMed ID: 4980004
    [No Abstract]   [Full Text] [Related]  

  • 40. Basics of compounding: implementing United States pharmacopeia chapter <795> pharmaceutical compounding--nonsterile preparations, part 4.
    Allen LV
    Int J Pharm Compd; 2012; 16(1):64-8. PubMed ID: 23050315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.